January 31, 2011 – An oncology systems provider has launched The Year of Radiotherapy, an initiative to raise awareness of radiotherapy as a cost-effective, cutting-edge treatment that can help cure cancer. Oncology Systems Limited (OSL) launched the program in response to data from Cancer Research UK.

According to figures published by Cancer Research UK, only one in 10 people know that radiotherapy helps cure 40 percent of cancer patients. A report from the national charity estimates that only 38 percent of cancer patients in England are getting radiotherapy, although research shows that up to 50 percent might benefit.

"We need to dispel the myths about radiotherapy and associated side effects and make people more aware of the benefits of the latest treatments,” said Julie Mead, clinical director of OSL. “But we also need to make sure that these treatments are available across the country. The U.K. lags behind America and Europe in introducing the new, more targeted radiotherapy technology that is available. Rather than update and reinvest in technology that's essentially been around for the last 40 or so years, it's time we made sure that every cancer patient in the U.K. has access to the best treatment."

"There's no doubt that our survival rates have risen and our treatment has improved almost beyond recognition,” said Sir Mike Richards, who launched OSL’s latest TomoTherapy installation at Nottingham City Hospital. “Our aim is to match the best in the world. With the TomoTherapy machine there will be treatments that people from the East Midlands and beyond will be able to access for the first time. I'm sure people from other trusts will come here to look for ideas for future treatment."

OSL is the U.K. and Ireland's exclusive distributor of the helical TomoTherapy treatment machine, which provides precise, targeted, image guided intensity modulated radiotherapy. There are more than 300 installations of the machine worldwide, but just six hospitals using the technology in the U.K.

For more information: www.osl.uk.com


Related Content

News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
Subscribe Now